Impaired immunogenicity of BNT162b2 anti-SARS-CoV-2 vaccine in patients treated for solid tumors Article Swipe
Jérôme Barrière
,
Emmanuel Chamorey
,
Zoubir Adjtoutah
,
O. Castelnau
,
Aba Mahamat
,
S. Di Marco
,
Emmanuel Petit
,
A. Leysalle
,
V. Raimondi
,
Michel Carlès
·
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1016/j.annonc.2021.04.019
YOU?
·
· 2021
· Open Access
·
· DOI: https://doi.org/10.1016/j.annonc.2021.04.019
Related Topics
Concepts
Metadata
- Type
- letter
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.annonc.2021.04.019
- http://www.annalsofoncology.org/article/S0923753421011832/pdf
- OA Status
- bronze
- Cited By
- 134
- References
- 5
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W3158078097
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W3158078097Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.annonc.2021.04.019Digital Object Identifier
- Title
-
Impaired immunogenicity of BNT162b2 anti-SARS-CoV-2 vaccine in patients treated for solid tumorsWork title
- Type
-
letterOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2021Year of publication
- Publication date
-
2021-04-28Full publication date if available
- Authors
-
Jérôme Barrière, Emmanuel Chamorey, Zoubir Adjtoutah, O. Castelnau, Aba Mahamat, S. Di Marco, Emmanuel Petit, A. Leysalle, V. Raimondi, Michel CarlèsList of authors in order
- Landing page
-
https://doi.org/10.1016/j.annonc.2021.04.019Publisher landing page
- PDF URL
-
https://www.annalsofoncology.org/article/S0923753421011832/pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://www.annalsofoncology.org/article/S0923753421011832/pdfDirect OA link when available
- Concepts
-
Medicine, Vaccination, Immunogenicity, Booster dose, Family medicine, Population, Cancer, Internal medicine, Pediatrics, Oncology, Immunology, Immunization, Immune system, Environmental healthTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
134Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 3, 2024: 10, 2023: 24, 2022: 50, 2021: 47Per-year citation counts (last 5 years)
- References (count)
-
5Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W3158078097 |
|---|---|
| doi | https://doi.org/10.1016/j.annonc.2021.04.019 |
| ids.doi | https://doi.org/10.1016/j.annonc.2021.04.019 |
| ids.mag | 3158078097 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/33932508 |
| ids.openalex | https://openalex.org/W3158078097 |
| fwci | 9.58182484 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000914 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Antibodies, Viral |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D000090982 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | BNT162 Vaccine |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D000086382 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | COVID-19 |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D000086663 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | COVID-19 Vaccines |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D006801 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Humans |
| mesh[5].qualifier_ui | Q000188 |
| mesh[5].descriptor_ui | D009369 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | drug therapy |
| mesh[5].descriptor_name | Neoplasms |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D014612 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Vaccines |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D000914 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Antibodies, Viral |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D000090982 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | BNT162 Vaccine |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D000086382 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | COVID-19 |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D000086663 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | COVID-19 Vaccines |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D006801 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Humans |
| mesh[12].qualifier_ui | Q000188 |
| mesh[12].descriptor_ui | D009369 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | drug therapy |
| mesh[12].descriptor_name | Neoplasms |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D014612 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Vaccines |
| type | letter |
| title | Impaired immunogenicity of BNT162b2 anti-SARS-CoV-2 vaccine in patients treated for solid tumors |
| biblio.issue | 8 |
| biblio.volume | 32 |
| biblio.last_page | 1055 |
| biblio.first_page | 1053 |
| topics[0].id | https://openalex.org/T10118 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9997000098228455 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | SARS-CoV-2 and COVID-19 Research |
| topics[1].id | https://openalex.org/T10340 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9950000047683716 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2713 |
| topics[1].subfield.display_name | Epidemiology |
| topics[1].display_name | Hepatitis B Virus Studies |
| topics[2].id | https://openalex.org/T10158 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.993399977684021 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Cancer Immunotherapy and Biomarkers |
| is_xpac | False |
| apc_list.value | 4060 |
| apc_list.currency | USD |
| apc_list.value_usd | 4060 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9021929502487183 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C22070199 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6726284623146057 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q192995 |
| concepts[1].display_name | Vaccination |
| concepts[2].id | https://openalex.org/C2780868878 |
| concepts[2].level | 3 |
| concepts[2].score | 0.5306564569473267 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1660197 |
| concepts[2].display_name | Immunogenicity |
| concepts[3].id | https://openalex.org/C12590561 |
| concepts[3].level | 4 |
| concepts[3].score | 0.5000121593475342 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q2920497 |
| concepts[3].display_name | Booster dose |
| concepts[4].id | https://openalex.org/C512399662 |
| concepts[4].level | 1 |
| concepts[4].score | 0.48997464776039124 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q3505712 |
| concepts[4].display_name | Family medicine |
| concepts[5].id | https://openalex.org/C2908647359 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4626487195491791 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q2625603 |
| concepts[5].display_name | Population |
| concepts[6].id | https://openalex.org/C121608353 |
| concepts[6].level | 2 |
| concepts[6].score | 0.44569140672683716 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[6].display_name | Cancer |
| concepts[7].id | https://openalex.org/C126322002 |
| concepts[7].level | 1 |
| concepts[7].score | 0.4366283714771271 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[7].display_name | Internal medicine |
| concepts[8].id | https://openalex.org/C187212893 |
| concepts[8].level | 1 |
| concepts[8].score | 0.33928269147872925 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q123028 |
| concepts[8].display_name | Pediatrics |
| concepts[9].id | https://openalex.org/C143998085 |
| concepts[9].level | 1 |
| concepts[9].score | 0.3345756530761719 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[9].display_name | Oncology |
| concepts[10].id | https://openalex.org/C203014093 |
| concepts[10].level | 1 |
| concepts[10].score | 0.27575230598449707 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[10].display_name | Immunology |
| concepts[11].id | https://openalex.org/C2780801004 |
| concepts[11].level | 3 |
| concepts[11].score | 0.11115667223930359 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q1415366 |
| concepts[11].display_name | Immunization |
| concepts[12].id | https://openalex.org/C8891405 |
| concepts[12].level | 2 |
| concepts[12].score | 0.08473131060600281 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[12].display_name | Immune system |
| concepts[13].id | https://openalex.org/C99454951 |
| concepts[13].level | 1 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[13].display_name | Environmental health |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9021929502487183 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/vaccination |
| keywords[1].score | 0.6726284623146057 |
| keywords[1].display_name | Vaccination |
| keywords[2].id | https://openalex.org/keywords/immunogenicity |
| keywords[2].score | 0.5306564569473267 |
| keywords[2].display_name | Immunogenicity |
| keywords[3].id | https://openalex.org/keywords/booster-dose |
| keywords[3].score | 0.5000121593475342 |
| keywords[3].display_name | Booster dose |
| keywords[4].id | https://openalex.org/keywords/family-medicine |
| keywords[4].score | 0.48997464776039124 |
| keywords[4].display_name | Family medicine |
| keywords[5].id | https://openalex.org/keywords/population |
| keywords[5].score | 0.4626487195491791 |
| keywords[5].display_name | Population |
| keywords[6].id | https://openalex.org/keywords/cancer |
| keywords[6].score | 0.44569140672683716 |
| keywords[6].display_name | Cancer |
| keywords[7].id | https://openalex.org/keywords/internal-medicine |
| keywords[7].score | 0.4366283714771271 |
| keywords[7].display_name | Internal medicine |
| keywords[8].id | https://openalex.org/keywords/pediatrics |
| keywords[8].score | 0.33928269147872925 |
| keywords[8].display_name | Pediatrics |
| keywords[9].id | https://openalex.org/keywords/oncology |
| keywords[9].score | 0.3345756530761719 |
| keywords[9].display_name | Oncology |
| keywords[10].id | https://openalex.org/keywords/immunology |
| keywords[10].score | 0.27575230598449707 |
| keywords[10].display_name | Immunology |
| keywords[11].id | https://openalex.org/keywords/immunization |
| keywords[11].score | 0.11115667223930359 |
| keywords[11].display_name | Immunization |
| keywords[12].id | https://openalex.org/keywords/immune-system |
| keywords[12].score | 0.08473131060600281 |
| keywords[12].display_name | Immune system |
| language | en |
| locations[0].id | doi:10.1016/j.annonc.2021.04.019 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S41454044 |
| locations[0].source.issn | 0923-7534, 1569-8041 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0923-7534 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Annals of Oncology |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | publisher-specific-oa |
| locations[0].pdf_url | http://www.annalsofoncology.org/article/S0923753421011832/pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/publisher-specific-oa |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Annals of Oncology |
| locations[0].landing_page_url | https://doi.org/10.1016/j.annonc.2021.04.019 |
| locations[1].id | pmid:33932508 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Annals of oncology : official journal of the European Society for Medical Oncology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/33932508 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:8080507 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Ann Oncol |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/8080507 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5004578546 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-1113-8948 |
| authorships[0].author.display_name | Jérôme Barrière |
| authorships[0].countries | FR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210150781 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Clinique Saint Jean, Cagnes-sur-Mer, France |
| authorships[0].institutions[0].id | https://openalex.org/I4210150781 |
| authorships[0].institutions[0].ror | https://ror.org/05trpty44 |
| authorships[0].institutions[0].type | facility |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210150781 |
| authorships[0].institutions[0].country_code | FR |
| authorships[0].institutions[0].display_name | Clinique Saint Jean Languedoc |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | J. Barrière |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Medical Oncology, Clinique Saint Jean, Cagnes-sur-Mer, France |
| authorships[1].author.id | https://openalex.org/A5023675047 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-6841-4571 |
| authorships[1].author.display_name | Emmanuel Chamorey |
| authorships[1].countries | FR |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210151846 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Biostatistics and Epidemiology, Centre Antoine Lacassagne, Nice, France |
| authorships[1].institutions[0].id | https://openalex.org/I4210151846 |
| authorships[1].institutions[0].ror | https://ror.org/05hmfw828 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210151846 |
| authorships[1].institutions[0].country_code | FR |
| authorships[1].institutions[0].display_name | Centre Antoine Lacassagne |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | E. Chamorey |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Biostatistics and Epidemiology, Centre Antoine Lacassagne, Nice, France |
| authorships[2].author.id | https://openalex.org/A5037715153 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Zoubir Adjtoutah |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Biology, Cerballiance, Cagnes-sur-Mer, France |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Z. Adjtoutah |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Biology, Cerballiance, Cagnes-sur-Mer, France |
| authorships[3].author.id | https://openalex.org/A5028833926 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-7422-294X |
| authorships[3].author.display_name | O. Castelnau |
| authorships[3].countries | FR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210150781 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Clinique Saint Jean, Cagnes-sur-Mer, France |
| authorships[3].institutions[0].id | https://openalex.org/I4210150781 |
| authorships[3].institutions[0].ror | https://ror.org/05trpty44 |
| authorships[3].institutions[0].type | facility |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210150781 |
| authorships[3].institutions[0].country_code | FR |
| authorships[3].institutions[0].display_name | Clinique Saint Jean Languedoc |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | O. Castelnau |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Medical Oncology, Clinique Saint Jean, Cagnes-sur-Mer, France |
| authorships[4].author.id | https://openalex.org/A5062696563 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-8755-0424 |
| authorships[4].author.display_name | Aba Mahamat |
| authorships[4].countries | FR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210150781 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Clinique Saint Jean, Cagnes-sur-Mer, France |
| authorships[4].institutions[0].id | https://openalex.org/I4210150781 |
| authorships[4].institutions[0].ror | https://ror.org/05trpty44 |
| authorships[4].institutions[0].type | facility |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210150781 |
| authorships[4].institutions[0].country_code | FR |
| authorships[4].institutions[0].display_name | Clinique Saint Jean Languedoc |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | A. Mahamat |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Medical Oncology, Clinique Saint Jean, Cagnes-sur-Mer, France |
| authorships[5].author.id | https://openalex.org/A5113768817 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | S. Di Marco |
| authorships[5].countries | FR |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210150781 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Clinique Saint Jean, Cagnes-sur-Mer, France |
| authorships[5].institutions[0].id | https://openalex.org/I4210150781 |
| authorships[5].institutions[0].ror | https://ror.org/05trpty44 |
| authorships[5].institutions[0].type | facility |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210150781 |
| authorships[5].institutions[0].country_code | FR |
| authorships[5].institutions[0].display_name | Clinique Saint Jean Languedoc |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | S. Marco |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Medical Oncology, Clinique Saint Jean, Cagnes-sur-Mer, France |
| authorships[6].author.id | https://openalex.org/A5054293365 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-9347-2554 |
| authorships[6].author.display_name | Emmanuel Petit |
| authorships[6].countries | FR |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210150781 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Clinique Saint Jean, Cagnes-sur-Mer, France |
| authorships[6].institutions[0].id | https://openalex.org/I4210150781 |
| authorships[6].institutions[0].ror | https://ror.org/05trpty44 |
| authorships[6].institutions[0].type | facility |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210150781 |
| authorships[6].institutions[0].country_code | FR |
| authorships[6].institutions[0].display_name | Clinique Saint Jean Languedoc |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | E. Petit |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Medical Oncology, Clinique Saint Jean, Cagnes-sur-Mer, France |
| authorships[7].author.id | https://openalex.org/A5108567368 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | A. Leysalle |
| authorships[7].countries | FR |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210150781 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Radiation Oncology, Clinique Saint Jean, Cagnes-sur-Mer, France |
| authorships[7].institutions[0].id | https://openalex.org/I4210150781 |
| authorships[7].institutions[0].ror | https://ror.org/05trpty44 |
| authorships[7].institutions[0].type | facility |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210150781 |
| authorships[7].institutions[0].country_code | FR |
| authorships[7].institutions[0].display_name | Clinique Saint Jean Languedoc |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | A. Leysalle |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Radiation Oncology, Clinique Saint Jean, Cagnes-sur-Mer, France |
| authorships[8].author.id | https://openalex.org/A5016935510 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | V. Raimondi |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Biology, Cerballiance, Cagnes-sur-Mer, France |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | V. Raimondi |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Biology, Cerballiance, Cagnes-sur-Mer, France |
| authorships[9].author.id | https://openalex.org/A5056317594 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-5485-1511 |
| authorships[9].author.display_name | Michel Carlès |
| authorships[9].countries | FR |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I3018988418 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Infectious Disease, Centre Hospitalo-Universitaire de Nice, Nice, France |
| authorships[9].institutions[0].id | https://openalex.org/I3018988418 |
| authorships[9].institutions[0].ror | https://ror.org/05qsjq305 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I3018988418 |
| authorships[9].institutions[0].country_code | FR |
| authorships[9].institutions[0].display_name | Centre Hospitalier Universitaire de Nice |
| authorships[9].author_position | last |
| authorships[9].raw_author_name | M. Carles |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Infectious Disease, Centre Hospitalo-Universitaire de Nice, Nice, France |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | http://www.annalsofoncology.org/article/S0923753421011832/pdf |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Impaired immunogenicity of BNT162b2 anti-SARS-CoV-2 vaccine in patients treated for solid tumors |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10118 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9997000098228455 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | SARS-CoV-2 and COVID-19 Research |
| related_works | https://openalex.org/W1552738310, https://openalex.org/W4250292386, https://openalex.org/W2470318958, https://openalex.org/W2428121789, https://openalex.org/W1548104248, https://openalex.org/W2030908446, https://openalex.org/W3042894437, https://openalex.org/W2403806215, https://openalex.org/W1585253481, https://openalex.org/W4205534188 |
| cited_by_count | 134 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 3 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 10 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 24 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 50 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 47 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1016/j.annonc.2021.04.019 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S41454044 |
| best_oa_location.source.issn | 0923-7534, 1569-8041 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0923-7534 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Annals of Oncology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | publisher-specific-oa |
| best_oa_location.pdf_url | http://www.annalsofoncology.org/article/S0923753421011832/pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/publisher-specific-oa |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Annals of Oncology |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.annonc.2021.04.019 |
| primary_location.id | doi:10.1016/j.annonc.2021.04.019 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S41454044 |
| primary_location.source.issn | 0923-7534, 1569-8041 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0923-7534 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Annals of Oncology |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | publisher-specific-oa |
| primary_location.pdf_url | http://www.annalsofoncology.org/article/S0923753421011832/pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/publisher-specific-oa |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Annals of Oncology |
| primary_location.landing_page_url | https://doi.org/10.1016/j.annonc.2021.04.019 |
| publication_date | 2021-04-28 |
| publication_year | 2021 |
| referenced_works | https://openalex.org/W3112675846, https://openalex.org/W3128744449, https://openalex.org/W3137814380, https://openalex.org/W2130251483, https://openalex.org/W2109928588 |
| referenced_works_count | 5 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 100 |
| cited_by_percentile_year.min | 97 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 10 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.6600000262260437 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.98296147 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |